Press release
Major Force in the Hyperimmune Globulins Market 2025: Rising Infectious Disease Prevalence Fuels Growth In The Hyperimmune Globulins Market
Major Force in the Hyperimmune Globulins Market
The market for hyperimmune globulins has seen robust growth in the past years. It's projected to increase from a worth of $1.91 billion in 2024 to a value of $2.06 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.8%. The notable growth in the previous period can be credited to enhanced governmental assistance and a surge in healthcare spending.
Expectations are high for a robust growth in the hyperimmune globulins market in the forthcoming years, with projections estimating a surge to $2.76 billion by 2029 at a compound annual growth rate (CAGR) of 7.6%. The anticipated growth during this period is linked to the escalating incidence of infectious diseases, enhanced awareness of the advantages of hyperimmune globulin injections, amplified demand for immunoglobulins, growing cases of alpha-1 antitrypsin deficiency, and an increase in immune deficiencies. Notably, significant trends forecasted for this period encompass technology advancements and innovations, heightened investments in research and development, growing demand for passive immunity treatments, progress in plasma-derived therapies, and advanced techniques in manufacturing technology.
What Factors Are Propelling the Expansion of the Hyperimmune Globulins Market?
The escalating incidence of infectious diseases is set to spur the hyperimmune globulin market's advancement. Such diseases are triggered by harmful pathogens such as viruses, bacteria, fungi, and parasites that penetrate the human body. The rise in infectious diseases owes its roots to aspects like antimicrobial resistance, climatic alterations, and population increase. Hyperimmune globulins are deployed to deliver immediate passive immunity against specific pathogens in the face of infectious diseases, thereby enabling prevention or cure of illnesses such as rabies, hepatitis B, or tetanus. For example, as per the Centers for Disease Control and Prevention, a US-based government entity, there was a substantial increase of about 17% in chronic hepatitis B cases in the US, escalating from 14,229 cases in 2021 to 16,729 scenarios in 2022 in April 2024. Thus, the escalating incidence of infectious diseases propels the hyperimmune globulin market's growth. As for the Hyperimmune Globulins Market Driver, government strategies for healthcare research, and development serve to amplify the growth of the hyperimmune globulins market. There's a heightened interest in such strategies given the escalating need for innovative medical answers and tackling newfound health stumbling blocks. Such strategies aid in the progression and availability of hyperimmune globulins effectively battling against specific infectious diseases. To illustrate, in 2022, the Department of Health and Social Care, a UK government body, informed about a £260 million (or US $270.65 million) funding announced by the UK government to bolster healthcare research and production. The Business, Energy, and Industrial Strategy (BEIS) and the Department of Health and Social Care formulated this support for NHS-led health research in diagnostics and treatment via new platforms safeguarding privacy and clinical research utilities, alongside £60 million (US $63.60 million) devoted for augmenting life sciences production in the UK. Thus, the amplifying government efforts in healthcare research and development propel the hyperimmune globulins market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16448&type=smp
Who Are the Major Industry Players Fueling Hyperimmune Globulins Market Expansion?
Major companies operating in the hyperimmune globulins market are F. Hoffmann-La Roche AG, Bayer AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Ltd., Fresenius Kabi AG, Grifols SA, Octapharma AG, Shanghai RAAS Blood Products Co. Ltd., Emergent BioSolutions Inc., Kedrion Biopharma Inc., LFB SA, Hualan Biological Engineering Inc., FFF Enterprises Inc., Taibang Biologic Group, Bio Products Laboratory (BPL) Ltd., ADMA Biologics, Cangene Corporation, Kamada Ltd., Saol Therapeutics Inc., Omrix Biopharmaceuticals Ltd., Shire, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., BioCare Inc.
How Is the Segmentation of the Hyperimmune Globulins Market Defined?
The hyperimmune globulins market covered in this report is segmented -
1) By Type: Hepatitis B Hyperimmune Globulin, Rabies Hyperimmune Globulin, Tetanus Hyperimmune Globulin, Cytomegalovirus (CMV) Hyperimmune Globulin, Varicella-Zoster Virus (VZV) Hyperimmune Globulin, Respiratory Syncytial Virus (RSV) Hyperimmune Globulin, Other Types
2) By Route Of Administration: Intramuscular, Intravenous
3) By Application: Government Institution, Private Sector, Other Applications
Subsegments:
1) By Hepatitis B Hyperimmune Globulin: Intramuscular Hepatitis B Hyperimmune Globulin, Intravenous Hepatitis B Hyperimmune Globulin
2) By Rabies Hyperimmune Globulin: Rabies Immune Globulin (Human), Rabies Immune Globulin (Equine)
3) By Tetanus Hyperimmune Globulin: Tetanus Immune Globulin (Human), Tetanus Immune Globulin (Equine)
4) By Cytomegalovirus (Cmv) Hyperimmune Globulin: Cmv Immune Globulin For Organ Transplantation, Cmv Immune Globulin For Neonatal Infection
5) By Varicella-Zoster Virus (Vzv) Hyperimmune Globulin: Vzv Immune Globulin For Post-Exposure Prophylaxis, Vzv Immune Globulin For Immunocompromised Patients
6) By Respiratory Syncytial Virus (Rsv) Hyperimmune Globulin: Rsv Immune Globulin For Infants And Children, Rsv Immune Globulin For Adults With Respiratory Conditions
7) By Other Types: Diphtheria Hyperimmune Globulin, Botulism Hyperimmune Globulin, Other Specialized Hyperimmune Globulins
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/hyperimmune-globulins-global-market-report
What Is the Leading Region in the Hyperimmune Globulins Market?
North America was the largest region in the hyperimmune globulins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperimmune globulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Hyperimmune Globulins Global Market Report?
- Market Size Analysis: Analyze the Hyperimmune Globulins Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Hyperimmune Globulins Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Hyperimmune Globulins Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Hyperimmune Globulins Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16448
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Major Force in the Hyperimmune Globulins Market 2025: Rising Infectious Disease Prevalence Fuels Growth In The Hyperimmune Globulins Market here
News-ID: 3863641 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Globulin
Global Rho(D) Immune Globulin Market Imapct of AI and Automation
Rho(D) Immune Globulin Market Impact of AI and Automation
The Rho(D) immune globulin market experienced notable growth in 2022, with its market size valued at approximately $3.4 billion. The compound annual growth rate (CAGR) during this period was around 5.2%, reflecting a steady increase in demand for this critical immunoglobulin used in preventing Rh incompatibility during pregnancy. The market's expansion is driven by heightened awareness of Rh disease, increasing prevalence of…
Gamma Globulin Market 2030 Global Share, Key Country Analysis and Forecasts
Global Gamma Globulin Market Report 2023 is a professional and in-depth survey on the current state of the StandardDrywall Cleanrooms Industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The StandardDrywall Cleanrooms Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00021167?utm_source=OpenPR&utm_medium=10791
Key Players Analysis:
Grifols, S.A.
Baxter
Octapharma AG
Biotest AG
Kedrion S.p.A
ADMA…
Anthrax Immune Globulin Market Analysis By Top Keyplayers - Emergent Biosolution …
The "Anthrax Immune Globulin Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Anthrax Immune Globulin Market, 2024-2031
Verified Market Research's most recent report, "Anthrax Immune Globulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides…
A Comprehensive Analysis of the Global Rabies Immune Globulin Market
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧:
Welcome to our comprehensive exploration of the Global Rabies Immune Globulin Market. In this blog, we delve into the market dynamics, trends, and COVID-19 impact analysis to provide valuable insights for stakeholders, investors, and enthusiasts alike.
𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
The global rabies immune globulin market has witnessed significant growth and evolution over the years, driven by advancements in technology, rising awareness about rabies prevention, and increased investments in healthcare infrastructure. The market is…
Gamma Globulin Market Size, Players, Revenue Analysis 2023-2030
Gamma Globulin Market Overview 2023:
The Gamma Globulin Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the Gamma Globulin market. This report explores all the key factors affecting the growth of the Gamma Globulin…
Global Gamma Globulin Market Research Report
This report studies the global Gamma Globulin market status and forecast, categorizes the global Gamma Globulin market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Grifols Baxter Octapharma Biotest Kedrion Geographically, this report studies the top producers and consumers, focuses on product…
